BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 12, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Dec. 7, 2021

Dec. 7, 2021
Med-tech firms raising money in public or private financings, including: Limbix Health, Proov.
Read More

Aiming to build a better ADC, Emergence raises $98M in series A

Dec. 7, 2021
By Nuala Moran
LONDON – Europe’s latest antibody-drug conjugate (ADC) specialist, Emergence Therapeutics AG, will be going head to head with pioneer Seagen Inc.’s approved ADC, Padcev, after raising €87 million (US$97.9 million) in a series A round.
Read More

Odyssey’s epic series A reaps $218M for ‘been there, done that’ dream team

Dec. 7, 2021
By Randy Osborne
Odyssey Therapeutics Inc. launched with a whopping $218 million series A round, the year’s second-largest, to fuel work by almost 100 employees recruited in the past few months, mostly from big pharma firms.
Read More

Financings for Dec. 7, 2021

Dec. 7, 2021
Biopharmas raising money in public or private financings, including: Aditxt, Bavarian Nordic, Context, Mei, Metis.
Read More
Dental X-ray

Wishbone raises $3M to ramp commercialization of its dental implant bone regeneration technology

Dec. 6, 2021
By Bernard Banga
PARIS – Wishbone SA closed a $3 million funding round, which should allow it to obtain the CE mark prior to launching its range of products in Europe based on bone regeneration technology for reconstructive dental surgery. “Thanks to this round, we are ramping scale and moving from R&D to the commercialization phase in Europe,” Daniel Bee, CEO of Wishbone, told BioWorld.
Read More

Financings for Dec. 6, 2021

Dec. 6, 2021
Med-tech firms raising money in public or private financings, including: Holmusk, KKT Technology, Trince.
Read More
A look back as we head into 2022

Top trends of 2021: R&D drives investment, SPACs dominate, but crowding, rising burn rates, new rules, threaten smooth ride

Dec. 6, 2021
By Karen Carey
Financings ramped up dramatically in 2015 with $68 billion collected, but the amount does not touch biopharma investment in the last two years. The industry has raised $113 billion in 2021, down from the $134.5 billion full year 2020 total, but more than every five-year combination total from the years 2000 to 2014. It is an increase of 65% over 2015, 200% over 2016, 118% over 2017, 68% over 2018 and 95% over 2019. Both IPOs ($23.7 billion) and venture capital rounds ($37.8 billion) have hit all-time records this year. But will the onslaught of money continue for the industry?
Read More

Financings for Dec. 6, 2021

Dec. 6, 2021
Biopharmas raising money in public or private financings, including: Bellicum, Benevolentai, Bioplus, Cyrus, Longeveron, Odyssey, Trince.
Read More
Photo of Harrison.ai co-founders with CEO

AI company Harrison.ai raises AU$129M in one of Australia’s largest series B rounds

Dec. 3, 2021
By Tamra Sami
PERTH, Australia – Health care artificial intelligence (AI) company Harrison.ai has raised AU$129 million (US$97 million) in a series B round that will expand the company’s global footprint by commercializing its comprehensive clinical AI applications.
Read More
Skeletal system

Medimaps seals $20M investment for AI bone imaging portfolio

Dec. 3, 2021
By Catherine Longworth
Medimaps Group SA has landed $20 million to expand its portfolio of bone health imaging software. The round was led by Swisscanto Invest, the asset management arm of the Zürcher Kantonalbank group, with participation from the Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. The company’s flagship product TBS (trabecular bone score) Insight is an artificial intelligence-powered medical software which provides information on bone quality from routine DXA and X-ray images.
Read More
Previous 1 2 … 392 393 394 395 396 397 398 399 400 … 643 644 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 9, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • CAR T cell attacking cancer cells

    Development and characterization of anti-CD19 in vivo CAR T therapy

    BioWorld Science
    Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
  • Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

    BioWorld Science
    The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing